Previous Article | Next Article 
Infection and Immunity, June 2000, p. 3164-3171, Vol. 68, No. 6
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Naturally Acquired and Vaccine-Elicited Antibodies
Block Erythrocyte Cytoadherence of the Plasmodium vivax
Duffy Binding Protein
Pascal
Michon,
Tresa
Fraser, and
John H.
Adams*
Department of Biological Sciences, University
of Notre Dame, Notre Dame, Indiana 46556-0369
Received 5 November 1999/Returned for modification 14 January
2000/Accepted 3 March 2000
Malaria merozoites require the presence of specific surface
receptors on the red blood cell for invasion. Plasmodium
vivax, requires the Duffy blood group antigen as an obligate
receptor for invasion. The parasite Duffy binding protein (DBP) is the ligand involved in this process, making the DBP a potential vaccine candidate. A preliminary objective was to study whether people exposed
to vivax malaria acquire antibodies that have the ability to block
erythrocyte cytoadherence to the PvDBP. In comparison, we studied the
immunogenicity of various recombinant DBP vaccines and investigated
their potential to induct antifunctional antibodies. In order to do so,
recombinant proteins to different regions of the putative ectodomain of
the DBP and a DNA vaccine were used to immunize laboratory animals. An
in vitro cytoadherence assay was used to investigate the presence of
antifunctional antibodies in plasmas from people naturally exposed to
vivax malaria, as well as in antisera obtained by animal vaccination.
Our results showed that human plasma from populations naturally exposed
to vivax malaria, as well as antisera obtained by vaccination using recombinant proteins, a DNA vaccine, and a synthetic peptide to DBP,
inhibited in vitro binding of human erythrocytes to the DBP ligand
domain (DBPII) in correlation to their previously measured antibody titer. Our results provide further evidence for the vaccine potential of this essential parasite adhesion molecule.
*
Corresponding author. Mailing address: Department of
Biological Sciences, University of Notre Dame, Notre Dame, IN
46556-0369. Phone: (219) 631-8676. Fax: (219) 631-7413. E-mail:
adams.20{at}nd.edu.
Infection and Immunity, June 2000, p. 3164-3171, Vol. 68, No. 6
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
MICHON, P., COLE-TOBIAN, J. L., DABOD, E., SCHOEPFLIN, S., IGU, J., SUSAPU, M., TARONGKA, N., ZIMMERMAN, P. A., REEDER, J. C., BEESON, J. G., SCHOFIELD, L., KING, C. L., MUELLER, I.
(2007). THE RISK OF MALARIAL INFECTIONS AND DISEASE IN PAPUA NEW GUINEAN CHILDREN. Am J Trop Med Hyg
76: 997-1008
[Abstract]
[Full Text]
-
Kim, S.-H., Hwang, S.-Y., Lee, Y.-S., Choi, I.-H., Park, S.-G., Kho, W.-G.
(2007). Single-Chain Antibody Fragment Specific for Plasmodium vivax Duffy Binding Protein. CVI
14: 726-731
[Abstract]
[Full Text]
-
AREVALO-HERRERA, M., CASTELLANOS, A., YAZDANI, S. S., SHAKRI, A. R., CHITNIS, C. E., DOMINIK, R., HERRERA, S.
(2005). IMMUNOGENICITY AND PROTECTIVE EFFICACY OF RECOMBINANT VACCINE BASED ON THE RECEPTOR-BINDING DOMAIN OF THE PLASMODIUM VIVAX DUFFY BINDING PROTEIN IN AOTUS MONKEYS. Am J Trop Med Hyg
73: 25-31
[Abstract]
[Full Text]
-
TRAN, T. M., OLIVEIRA-FERREIRA, J., MORENO, A., SANTOS, F., YAZDANI, S. S., CHITNIS, C. E., ALTMAN, J. D., MEYER, E. V-S., BARNWELL, J. W., GALINSKI, M. R.
(2005). COMPARISON OF IgG REACTIVITIES TO PLASMODIUM VIVAX MEROZOITE INVASION ANTIGENS IN A BRAZILIAN AMAZON POPULATION. Am J Trop Med Hyg
73: 244-255
[Abstract]
[Full Text]
-
CERAVOLO, I. P., BRUNA-ROMERO, O., BRAGA, E. M., FONTES, C. J. F., BRITO, C. F. A., SOUZA, J. M., KRETTLI, A. U., ADAMS, J. H., CARVALHO, L. H.
(2005). ANTI-PLASMODIUM VIVAX DUFFY BINDING PROTEIN ANTIBODIES MEASURE EXPOSURE TO MALARIA IN THE BRAZILIAN AMAZON. Am J Trop Med Hyg
72: 675-681
[Abstract]
[Full Text]
-
VanBuskirk, K. M., Sevova, E., Adams, J. H.
(2004). Conserved residues in the Plasmodium vivax Duffy-binding protein ligand domain are critical for erythrocyte receptor recognition. Proc. Natl. Acad. Sci. USA
101: 15754-15759
[Abstract]
[Full Text]
-
Ohas, E. A., Adams, J. H., Waitumbi, J. N., Orago, A. S. S., Barbosa, A., Lanar, D. E., Stoute, J. A.
(2004). Measurement of Antibody Levels against Region II of the Erythrocyte-Binding Antigen 175 of Plasmodium falciparum in an Area of Malaria Holoendemicity in Western Kenya. Infect. Immun.
72: 735-741
[Abstract]
[Full Text]
-
Xainli, J., Cole-Tobian, J. L., Baisor, M., Kastens, W., Bockarie, M., Yazdani, S. S., Chitnis, C. E., Adams, J. H., King, C. L.
(2003). Epitope-Specific Humoral Immunity to Plasmodium vivax Duffy Binding Protein. Infect. Immun.
71: 2508-2515
[Abstract]
[Full Text]
-
Xainli, J., Baisor, M., Kastens, W., Bockarie, M., Adams, J. H., King, C. L.
(2002). Age-Dependent Cellular Immune Responses to Plasmodium vivax Duffy Binding Protein in Humans. J. Immunol.
169: 3200-3207
[Abstract]
[Full Text]
-
Singh, S., Pandey, K., Chattopadhayay, R., Yazdani, S. S., Lynn, A., Bharadwaj, A., Ranjan, A., Chitnis, C.
(2001). Biochemical, Biophysical, and Functional Characterization of Bacterially Expressed and Refolded Receptor Binding Domain of Plasmodium vivax Duffy-binding Protein. J. Biol. Chem.
276: 17111-17116
[Abstract]
[Full Text]